GB201809946D0 - Prevention and treatment of cancer - Google Patents
Prevention and treatment of cancerInfo
- Publication number
- GB201809946D0 GB201809946D0 GBGB1809946.5A GB201809946A GB201809946D0 GB 201809946 D0 GB201809946 D0 GB 201809946D0 GB 201809946 A GB201809946 A GB 201809946A GB 201809946 D0 GB201809946 D0 GB 201809946D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (16)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1809946.5A GB201809946D0 (en) | 2018-06-18 | 2018-06-18 | Prevention and treatment of cancer |
CA3102743A CA3102743A1 (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
PCT/GB2019/051699 WO2019243801A1 (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
ARP190101686A AR115575A1 (en) | 2018-06-18 | 2019-06-18 | GREMLIN-1 ANTAGONIST FOR THE PREVENTION AND TREATMENT OF CANCER |
US17/253,660 US20210253688A1 (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
KR1020217001142A KR20210028191A (en) | 2018-06-18 | 2019-06-18 | GREMLIN-1 antagonists for preventing and treating cancer |
SG11202012312UA SG11202012312UA (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
BR112020025661-7A BR112020025661A2 (en) | 2018-06-18 | 2019-06-18 | anti-grem1 antagonist, anticancer agent, methods of treating a cancer and predicting a cancer, composition or kit, methods for detecting cancer, to determine whether a patient with or suspected of having or at risk of developing cancer is or not likely to respond to treatment with a chemotherapeutic agent, and to determine whether a patient with or suspected of having or at risk of developing cancer is likely to respond to treatment with a grem antagonist1 |
MX2020013808A MX2020013808A (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer. |
JP2020570158A JP2021528400A (en) | 2018-06-18 | 2019-06-18 | GREMLIN-1 antagonist for the prevention and treatment of cancer |
CN201980041089.7A CN112533632A (en) | 2018-06-18 | 2019-06-18 | GREMLIN-1 antagonists for the prevention and treatment of cancer |
EP19734460.9A EP3806898A1 (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
AU2019289176A AU2019289176A1 (en) | 2018-06-18 | 2019-06-18 | Gremlin-1 antagonist for the prevention and treatment of cancer |
IL279347A IL279347A (en) | 2018-06-18 | 2020-12-10 | Gremlin-1 antagonist for the prevention and treatment of cancer |
CL2020003249A CL2020003249A1 (en) | 2018-06-18 | 2020-12-15 | Gremlin-1 antagonist for the prevention and treatment of cancer |
CONC2020/0015923A CO2020015923A2 (en) | 2018-06-18 | 2020-12-17 | Gremlin-1 antagonist for the prevention and treatment of cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1809946.5A GB201809946D0 (en) | 2018-06-18 | 2018-06-18 | Prevention and treatment of cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201809946D0 true GB201809946D0 (en) | 2018-08-01 |
Family
ID=63042307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1809946.5A Ceased GB201809946D0 (en) | 2018-06-18 | 2018-06-18 | Prevention and treatment of cancer |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR115575A1 (en) |
GB (1) | GB201809946D0 (en) |
-
2018
- 2018-06-18 GB GBGB1809946.5A patent/GB201809946D0/en not_active Ceased
-
2019
- 2019-06-18 AR ARP190101686A patent/AR115575A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR115575A1 (en) | 2021-02-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1252873A1 (en) | Vaccines for treatment and prevention of cancer | |
IL268814A (en) | Compositions and methods for treatment of cancer | |
IL279347A (en) | Gremlin-1 antagonist for the prevention and treatment of cancer | |
FI3773689T3 (en) | Antigenic peptides for prevention and treatment of cancer | |
SG11202011117VA (en) | Treatment of cancer | |
EP3749342A4 (en) | Bacteriophage for treatment and prevention of bacteria-associated cancers | |
ZA202000558B (en) | Prevention and/or treatment of neurodegenerative disease | |
IL276905A (en) | Treatment and prevention of pre-eclampsia | |
IL276203A (en) | Compositions and methods of treating cancer | |
IL272147A (en) | Methods and compositions for the treatment of cancer | |
IL267613A (en) | Treatment of pancreatic cancer | |
EP3579840C0 (en) | Treatment of cancer and inhibition of metastasis | |
FI3630112T3 (en) | Combination of regorafenib and nivolumab for treating cancer | |
EP3490971A4 (en) | Methods of treating and preventing cancer treatment side effects | |
IL280262A (en) | Compositions and methods for the treatment of cancer | |
EP3987032A4 (en) | Methods and compositions for the treatment of cancer | |
IL270306A (en) | Prevention and treatment of pre-myeloid and myeloid malignancies | |
GB201815694D0 (en) | Prevention and treatment of cancer | |
GB201809946D0 (en) | Prevention and treatment of cancer | |
GB201815000D0 (en) | Treatment of hypothroidism and related conditions | |
GB201918815D0 (en) | Treatment of cancer | |
IL276121A (en) | Treatment and prevention of seed allergies | |
IL274748A (en) | Improved treatment of cancer | |
GB201816542D0 (en) | Treatment and prevention of malaria | |
GB201820975D0 (en) | Methods of cancer treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |